Tien-Yuan Wu

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Venues

Therapeutic advances in drug safety

Medicine

Biomolecules

Integrative cancer therapies

Tzu Chi University

Rutgers The State University of New Jersey (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Tzu Chi University Mar 01 2015

Taiwan

Assistant Professor :: Pharmacology

Taipei Medical University

Taiwan

Fellow :: Oncology Medicine Development

Mount Sinai Hospital

United States

Fellow :: Black Family Stem Cell Institute, Department of Developmental and Regenerative Biology, Department of Oncological Sciences

Rutgers The State University of New Jersey

United States

Fellow :: Center for Cancer Prevention Research and Department of Pharmaceutics

Education History

Rutgers The State University of New Jersey

United States

PHD :: Pharmacy/Pharmaceutical Science

Publications

Ling-Yi Wang, Hui-Hsia Hsieh, Sung-Chao Chu, Wei-Chuan Chang, Yi-Ting Kuo, Tien-Yuan Wu
Oxaliplatin-associated shock in stage III colorectal cancer patients: real-world evidence in Taiwan. Therapeutic advances in drug safety 15 (2024)
Ling-Yi Wang, Hui-Hsia Hsieh, Sung-Chao Chu, Wei-Chuan Chang, Yi-Ting Kuo, Tien-Yuan Wu
Oxaliplatin-associated shock in stage III colorectal cancer patients: real-world evidence in Taiwan. Therapeutic advances in drug safety 15 (2024)
Hui-Hsia Hsieh, Tien-Yuan Wu, Chi-Hua Chen, Yu-Hung Kuo, Mann-Jen Hour
Survival Outcomes of Calcium Channel Blocker Therapy in Patients With Non-Small Cell Lung Cancer Treated With Epidermal Growth Factor Receptor Inhibitors: A Retrospective Study. Integrative cancer therapies 22 (2023)
Hui-Hsia Hsieh, Tien-Yuan Wu, Chi-Hua Chen, Mann-Jen Hour
Cost-effectiveness and clinical outcomes of intermittent/continuous proton pump inhibitors infusion in high bleeding risk of ulcers: A retrospective observational cohort study. Medicine 100 (49) (2022)
Chi-Hua Chen, Hui-Hsia Hsieh, Tien-Yuan Wu
Real-world prevalence of hepatitis B virus reactivation in cancer patients in Taiwan. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 27 (1) (2020)
Tien-Yuan Wu, Jia-Ni Lin, Zi-Yao Luo, Chuan-Jen Hsu, Jen-Shu Wang, Hung-Pin Wu
2,3,4',5-Tetrahydroxystilbene-2-O-β-D-Glucoside (THSG) Activates the Nrf2 Antioxidant Pathway and Attenuates Oxidative Stress-Induced Cell Death in Mouse Cochlear UB/OC-2 Cells. Biomolecules 10 (3) (2020)

Tien-Yuan Wu.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Tien-Yuan Wu